查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1140002

皮膚化妝品市場：按產品、按治療、按分銷渠道、按最終用戶：2021-2030 年全球機會分析和行業預測

Dermocosmetics Market By Product, By Treatment, By Distribution Channel, By End-user : Global Opportunity Analysis and Industry Forecast, 2021-2030
出版日期: | 出版商: Allied Market Research | 英文 310 Pages | 商品交期: 2-3個工作天內

價格

預計從 2022 年到 2030 年，全球皮膚化妝品市場將以 11.1% 的複合年增長率增長，從 2021 年的 511 億美元增加到 2030 年的 1304.606 億美元。

化妝品和皮膚科是兩個醫學流，它們結合在一起形成了皮膚化妝品。所有應用於皮膚和頭髮以治療皮膚問題（如乾性皮膚、油性皮膚、痤瘡、粉刺、斑點和痕跡）的化妝品都稱為皮膚化妝品。護膚品對化妝品的需求很大程度上是由於對其益處的認識不斷提高，預計該行業的技術進步將對未來幾年對皮膚化妝品的需求產生重大影響。

消費者越來越注重自己的外表，因為這與他們的個性相得益彰。為了減少老化、皺紋、粉刺、細紋等的影響，人們越來越願意花錢購買各種皮膚化妝品來保護和提亮皮膚。此外，由於客戶忙碌的生活方式和在線渠道上最便捷的購買方式，預計在整個預測期內，電子商務網站上的購物趨勢對護膚皮膚化妝品市場的表現至關重要。 .化妝品中的化學物質會對您的皮膚產生多種不利影響。化妝品製造商正在增加使用尖端技術的化妝品的銷售，例如推出使用天然成分和有吸引力的包裝的新產品。預測預計這些因素將加速市場的收入增長。

COVID-19 大流行已經關閉了大多數行業。進出口中斷、供應鏈問題以及數家製造設施的關閉推遲了新產品的生產。在大流行期間，對皮膚化妝品的需求略有增加，因為它們有效地維持了健康的皮膚護理。一些國家的封鎖使人們無法繼續預約治療。結果，他們能夠在家中繼續使用 Dermacosme 進行皮膚護理。

此外，由於政府的規定和指導方針，皮膚科醫生現在正在進行在線諮詢。然而，在大流行期間，高昂的產品成本和不斷變化的消費者偏好限制了市場的增長。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概覽

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特五力分析
  • 主要公司的定位
  • 市場動態
    • 驅動程序
    • 約束因素
    • 機會
  • COVID-19 影響分析
  • 價值鏈分析
  • 市場份額分析
  • 監管準則
  • 關鍵法規分析
  • 專利情況

第 4 章皮膚化妝品市場：按產品分類

  • 概覽
    • 市場規模和預測
  • 皮膚護理
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 頭髮護理
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 5 章皮膚化妝品市場：按治療方法

  • 概覽
    • 市場規模和預測
  • 皮膚
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 頭髮
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 6 章皮膚化妝品市場：按分銷渠道劃分

  • 概覽
    • 市場規模和預測
  • 藥房和零售店
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 在線
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 7 章皮膚化妝品市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 診所、醫療水療中心、沙龍
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 醫院
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 在家
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 8 章皮膚化妝品市場：按地區劃分

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機遇
    • 北美市場規模和預測：按產品分類
    • 北美市場規模和預測：按處理方法
    • 北美市場規模和預測：按分銷渠道
    • 北美市場規模和預測：按最終用戶分類
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機遇
    • 歐洲市場規模和預測：按產品分類
    • 歐洲市場規模和預測：按處理方法
    • 歐洲市場規模和預測：按分銷渠道
    • 歐洲市場規模和預測：按最終用戶分類
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 法國
      • 意大利
      • 西班牙
      • 英國
      • 其他歐洲
  • 亞太地區
    • 主要趨勢和機遇
    • 亞太市場規模和預測：按產品分類
    • 亞太地區市場規模及按處理方法預測
    • 亞太地區市場規模和預測：按分銷渠道
    • 亞太市場規模和預測：按最終用戶分類
    • 亞太地區的市場規模和預測：按國家/地區分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 澳大利亞
      • 其他亞太地區
  • LAMEA
    • 主要趨勢和機遇
    • LAMEA 市場規模和預測：按產品分類
    • LAMEA 市場規模和預測：按處理方法
    • LAMEA 市場規模和預測：按分銷渠道
    • LAMEA 市場規模和預測：按最終用戶分類
    • LAMEA 市場的市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國
      • 南非
      • 其他拉丁美洲地區

第 9 章商業條件

  • 簡介
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 競賽儀表板
  • 比賽熱圖
  • 主要發展

第 10 章公司簡介

  • johnson & johnson, inc.
  • Bausch Health Companies Inc.
  • galderma
  • Procter & Gamble
  • Allergan plc
  • L'Oreal S.A
  • beiersdorf
  • Kanebo Cosmetics Inc.
  • Estee Lauder Companies Inc.
  • Shiseido Company
Product Code: A11130

The global dermocosmetics market is envisioned to garner $13, 0460.6 million by 2030, growing from $51,100 million in 2021 at a CAGR of 11.1% from 2022 to 2030.

Cosmetics and dermatology are two medical streams that are combined together to form dermocosmetics. All cosmetics products that may be applied to the skin or hair and that address particular skin issues such as dry skin, oily skin, skin ailments including acne, pimples, blemishes, marks, and others are referred to as dermacosmetics. Need of cosmetics in skin care is majorly due to  rising awareness regarding its effectiveness and technological advancements in the industry are expected to have a significant impact on demand for dermacosmetics in the years to come.

Consumers are becoming more self-conscious about their appearance as it enhances their personality. In order to lessen the effects of aging, wrinkles, acne, and fine lines, they are increasingly preferring to spend more money on protecting and whitening their skin by using various dermocosmetic products. Furthermore, the trend towards shopping on e-commerce websites is projected to be essential for the performance of the skincare dermacosmetics market throughout the forecast period, due to customers' busy lifestyles and adopting most convenient ways to buy through online channel. Cosmetic products contain chemical compounds which can have a variety of negative effects on skin. Manufacturing businesses have used cutting-edge techniques to boost sales of their cosmetics items, such as introduction of new products with all-natural ingredients and attractive packaging. In the forecast, these factors are projected to accelerate the market revenue growth.

The majority of industries were shut down as a result of the COVID-19 pandemic. Import and export interruption, supply chain issues, and shutting down of several manufacturing facilities resulted in delaying the manufacturing of new products. Due to dermocosmetics' effectiveness in maintaining a healthy skincare routine during the pandemic, dermocosmetics witnessed a little boost in demand. Due to the lockdown in several countries, people were unable to continue their therapy appointments. As a result, they were able to continue practicing skincare using dermacosmetics at home itself.

Additionally, dermotologists started conducting online consultations, due to the restriction and guidelines provided by various governments. However, during the pandemic, high product costs and a change in consumer tastes restricted the market growth.

The key players profiled in the dermocosmetics market report include Johnson & Johnson, Bausch Health Companies Inc., Galderma, Procter & Gamble, AbbVie, L'Oreal, Beiersdorf, Kanebo Cosmetics Inc., Estee Lauder Companies, Shiseido Company, and ZO Skin Health Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the dermocosmetics market analysis from 2021 to 2030 to identify the prevailing dermocosmetics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the dermocosmetics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global dermocosmetics market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Skin Care
  • Hair Care

By Treatment

  • Skin
  • Hair

By Distribution Channel

  • Pharmacy and Retail Stores
  • Online

By End-user

  • Clinics, Medical Spas, and Salons
  • Hospitals
  • At-Home

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of Latin America
  • Key Market Players
    • johnson & johnson, inc.
    • Bausch Health Companies Inc.
    • galderma
    • Procter & Gamble
    • Allergan plc
    • L'Oreal S.A
    • beiersdorf
    • Kanebo Cosmetics Inc.
    • Estee Lauder Companies Inc.
    • Shiseido Company

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Value Chain Analysis
  • 3.8.Market Share Analysis
  • 3.9.Regulatory Guidelines
  • 3.10.Key Regulation Analysis
  • 3.11.Patent Landscape

CHAPTER 4: DERMOCOSMETICS MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Skin Care
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Hair Care
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: DERMOCOSMETICS MARKET, BY TREATMENT

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Skin
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Hair
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country

CHAPTER 6: DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Pharmacy and Retail Stores
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Online
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country

CHAPTER 7: DERMOCOSMETICS MARKET, BY END-USER

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 Clinics, Medical Spas, and Salons
    • 7.2.1 Key market trends, growth factors and opportunities
    • 7.2.2 Market size and forecast, by region
    • 7.2.3 Market analysis by country
  • 7.3 Hospitals
    • 7.3.1 Key market trends, growth factors and opportunities
    • 7.3.2 Market size and forecast, by region
    • 7.3.3 Market analysis by country
  • 7.4 At-Home
    • 7.4.1 Key market trends, growth factors and opportunities
    • 7.4.2 Market size and forecast, by region
    • 7.4.3 Market analysis by country

CHAPTER 8: DERMOCOSMETICS MARKET, BY REGION

  • 8.1 Overview
    • 8.1.1 Market size and forecast
  • 8.2 North America
    • 8.2.1 Key trends and opportunities
    • 8.2.2 North America Market size and forecast, by Product
    • 8.2.3 North America Market size and forecast, by Treatment
    • 8.2.4 North America Market size and forecast, by Distribution Channel
    • 8.2.5 North America Market size and forecast, by End-user
    • 8.2.6 North America Market size and forecast, by country
      • 8.2.6.1 U.S.
      • 8.2.6.1.1 Market size and forecast, by Product
      • 8.2.6.1.2 Market size and forecast, by Treatment
      • 8.2.6.1.3 Market size and forecast, by Distribution Channel
      • 8.2.6.1.4 Market size and forecast, by End-user
      • 8.2.6.2 Canada
      • 8.2.6.2.1 Market size and forecast, by Product
      • 8.2.6.2.2 Market size and forecast, by Treatment
      • 8.2.6.2.3 Market size and forecast, by Distribution Channel
      • 8.2.6.2.4 Market size and forecast, by End-user
      • 8.2.6.3 Mexico
      • 8.2.6.3.1 Market size and forecast, by Product
      • 8.2.6.3.2 Market size and forecast, by Treatment
      • 8.2.6.3.3 Market size and forecast, by Distribution Channel
      • 8.2.6.3.4 Market size and forecast, by End-user
  • 8.3 Europe
    • 8.3.1 Key trends and opportunities
    • 8.3.2 Europe Market size and forecast, by Product
    • 8.3.3 Europe Market size and forecast, by Treatment
    • 8.3.4 Europe Market size and forecast, by Distribution Channel
    • 8.3.5 Europe Market size and forecast, by End-user
    • 8.3.6 Europe Market size and forecast, by country
      • 8.3.6.1 Germany
      • 8.3.6.1.1 Market size and forecast, by Product
      • 8.3.6.1.2 Market size and forecast, by Treatment
      • 8.3.6.1.3 Market size and forecast, by Distribution Channel
      • 8.3.6.1.4 Market size and forecast, by End-user
      • 8.3.6.2 France
      • 8.3.6.2.1 Market size and forecast, by Product
      • 8.3.6.2.2 Market size and forecast, by Treatment
      • 8.3.6.2.3 Market size and forecast, by Distribution Channel
      • 8.3.6.2.4 Market size and forecast, by End-user
      • 8.3.6.3 Italy
      • 8.3.6.3.1 Market size and forecast, by Product
      • 8.3.6.3.2 Market size and forecast, by Treatment
      • 8.3.6.3.3 Market size and forecast, by Distribution Channel
      • 8.3.6.3.4 Market size and forecast, by End-user
      • 8.3.6.4 Spain
      • 8.3.6.4.1 Market size and forecast, by Product
      • 8.3.6.4.2 Market size and forecast, by Treatment
      • 8.3.6.4.3 Market size and forecast, by Distribution Channel
      • 8.3.6.4.4 Market size and forecast, by End-user
      • 8.3.6.5 United Kingdom
      • 8.3.6.5.1 Market size and forecast, by Product
      • 8.3.6.5.2 Market size and forecast, by Treatment
      • 8.3.6.5.3 Market size and forecast, by Distribution Channel
      • 8.3.6.5.4 Market size and forecast, by End-user
      • 8.3.6.6 Rest of Europe
      • 8.3.6.6.1 Market size and forecast, by Product
      • 8.3.6.6.2 Market size and forecast, by Treatment
      • 8.3.6.6.3 Market size and forecast, by Distribution Channel
      • 8.3.6.6.4 Market size and forecast, by End-user
  • 8.4 Asia-Pacific
    • 8.4.1 Key trends and opportunities
    • 8.4.2 Asia-Pacific Market size and forecast, by Product
    • 8.4.3 Asia-Pacific Market size and forecast, by Treatment
    • 8.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
    • 8.4.5 Asia-Pacific Market size and forecast, by End-user
    • 8.4.6 Asia-Pacific Market size and forecast, by country
      • 8.4.6.1 China
      • 8.4.6.1.1 Market size and forecast, by Product
      • 8.4.6.1.2 Market size and forecast, by Treatment
      • 8.4.6.1.3 Market size and forecast, by Distribution Channel
      • 8.4.6.1.4 Market size and forecast, by End-user
      • 8.4.6.2 Japan
      • 8.4.6.2.1 Market size and forecast, by Product
      • 8.4.6.2.2 Market size and forecast, by Treatment
      • 8.4.6.2.3 Market size and forecast, by Distribution Channel
      • 8.4.6.2.4 Market size and forecast, by End-user
      • 8.4.6.3 India
      • 8.4.6.3.1 Market size and forecast, by Product
      • 8.4.6.3.2 Market size and forecast, by Treatment
      • 8.4.6.3.3 Market size and forecast, by Distribution Channel
      • 8.4.6.3.4 Market size and forecast, by End-user
      • 8.4.6.4 South Korea
      • 8.4.6.4.1 Market size and forecast, by Product
      • 8.4.6.4.2 Market size and forecast, by Treatment
      • 8.4.6.4.3 Market size and forecast, by Distribution Channel
      • 8.4.6.4.4 Market size and forecast, by End-user
      • 8.4.6.5 Australia
      • 8.4.6.5.1 Market size and forecast, by Product
      • 8.4.6.5.2 Market size and forecast, by Treatment
      • 8.4.6.5.3 Market size and forecast, by Distribution Channel
      • 8.4.6.5.4 Market size and forecast, by End-user
      • 8.4.6.6 Rest of Asia-Pacific
      • 8.4.6.6.1 Market size and forecast, by Product
      • 8.4.6.6.2 Market size and forecast, by Treatment
      • 8.4.6.6.3 Market size and forecast, by Distribution Channel
      • 8.4.6.6.4 Market size and forecast, by End-user
  • 8.5 LAMEA
    • 8.5.1 Key trends and opportunities
    • 8.5.2 LAMEA Market size and forecast, by Product
    • 8.5.3 LAMEA Market size and forecast, by Treatment
    • 8.5.4 LAMEA Market size and forecast, by Distribution Channel
    • 8.5.5 LAMEA Market size and forecast, by End-user
    • 8.5.6 LAMEA Market size and forecast, by country
      • 8.5.6.1 Brazil
      • 8.5.6.1.1 Market size and forecast, by Product
      • 8.5.6.1.2 Market size and forecast, by Treatment
      • 8.5.6.1.3 Market size and forecast, by Distribution Channel
      • 8.5.6.1.4 Market size and forecast, by End-user
      • 8.5.6.2 Saudi Arabia
      • 8.5.6.2.1 Market size and forecast, by Product
      • 8.5.6.2.2 Market size and forecast, by Treatment
      • 8.5.6.2.3 Market size and forecast, by Distribution Channel
      • 8.5.6.2.4 Market size and forecast, by End-user
      • 8.5.6.3 United Arab Emirates
      • 8.5.6.3.1 Market size and forecast, by Product
      • 8.5.6.3.2 Market size and forecast, by Treatment
      • 8.5.6.3.3 Market size and forecast, by Distribution Channel
      • 8.5.6.3.4 Market size and forecast, by End-user
      • 8.5.6.4 South Africa
      • 8.5.6.4.1 Market size and forecast, by Product
      • 8.5.6.4.2 Market size and forecast, by Treatment
      • 8.5.6.4.3 Market size and forecast, by Distribution Channel
      • 8.5.6.4.4 Market size and forecast, by End-user
      • 8.5.6.5 Rest of Latin America
      • 8.5.6.5.1 Market size and forecast, by Product
      • 8.5.6.5.2 Market size and forecast, by Treatment
      • 8.5.6.5.3 Market size and forecast, by Distribution Channel
      • 8.5.6.5.4 Market size and forecast, by End-user

CHAPTER 9: COMPANY LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Key developments

CHAPTER 10: COMPANY PROFILES

  • 10.1 johnson & johnson, inc.
    • 10.1.1 Company overview
    • 10.1.2 Company snapshot
    • 10.1.3 Operating business segments
    • 10.1.4 Product portfolio
    • 10.1.5 Business performance
    • 10.1.6 Key strategic moves and developments
  • 10.2 Bausch Health Companies Inc.
    • 10.2.1 Company overview
    • 10.2.2 Company snapshot
    • 10.2.3 Operating business segments
    • 10.2.4 Product portfolio
    • 10.2.5 Business performance
    • 10.2.6 Key strategic moves and developments
  • 10.3 galderma
    • 10.3.1 Company overview
    • 10.3.2 Company snapshot
    • 10.3.3 Operating business segments
    • 10.3.4 Product portfolio
    • 10.3.5 Business performance
    • 10.3.6 Key strategic moves and developments
  • 10.4 Procter & Gamble
    • 10.4.1 Company overview
    • 10.4.2 Company snapshot
    • 10.4.3 Operating business segments
    • 10.4.4 Product portfolio
    • 10.4.5 Business performance
    • 10.4.6 Key strategic moves and developments
  • 10.5 Allergan plc
    • 10.5.1 Company overview
    • 10.5.2 Company snapshot
    • 10.5.3 Operating business segments
    • 10.5.4 Product portfolio
    • 10.5.5 Business performance
    • 10.5.6 Key strategic moves and developments
  • 10.6 L'Oreal S.A
    • 10.6.1 Company overview
    • 10.6.2 Company snapshot
    • 10.6.3 Operating business segments
    • 10.6.4 Product portfolio
    • 10.6.5 Business performance
    • 10.6.6 Key strategic moves and developments
  • 10.7 beiersdorf
    • 10.7.1 Company overview
    • 10.7.2 Company snapshot
    • 10.7.3 Operating business segments
    • 10.7.4 Product portfolio
    • 10.7.5 Business performance
    • 10.7.6 Key strategic moves and developments
  • 10.8 Kanebo Cosmetics Inc.
    • 10.8.1 Company overview
    • 10.8.2 Company snapshot
    • 10.8.3 Operating business segments
    • 10.8.4 Product portfolio
    • 10.8.5 Business performance
    • 10.8.6 Key strategic moves and developments
  • 10.9 Estee Lauder Companies Inc.
    • 10.9.1 Company overview
    • 10.9.2 Company snapshot
    • 10.9.3 Operating business segments
    • 10.9.4 Product portfolio
    • 10.9.5 Business performance
    • 10.9.6 Key strategic moves and developments
  • 10.10 Shiseido Company
    • 10.10.1 Company overview
    • 10.10.2 Company snapshot
    • 10.10.3 Operating business segments
    • 10.10.4 Product portfolio
    • 10.10.5 Business performance
    • 10.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 2. DERMOCOSMETICS MARKET SIZE, FOR SKIN CARE, BY REGION, 2021-2030 ($MILLION)
  • TABLE 3. DERMOCOSMETICS MARKET FOR SKIN CARE BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 4. DERMOCOSMETICS MARKET SIZE, FOR HAIR CARE, BY REGION, 2021-2030 ($MILLION)
  • TABLE 5. DERMOCOSMETICS MARKET FOR HAIR CARE BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 6. GLOBAL DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 7. DERMOCOSMETICS MARKET SIZE, FOR SKIN, BY REGION, 2021-2030 ($MILLION)
  • TABLE 8. DERMOCOSMETICS MARKET FOR SKIN BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 9. DERMOCOSMETICS MARKET SIZE, FOR HAIR, BY REGION, 2021-2030 ($MILLION)
  • TABLE 10. DERMOCOSMETICS MARKET FOR HAIR BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 11. GLOBAL DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 12. DERMOCOSMETICS MARKET SIZE, FOR PHARMACY AND RETAIL STORES, BY REGION, 2021-2030 ($MILLION)
  • TABLE 13. DERMOCOSMETICS MARKET FOR PHARMACY AND RETAIL STORES BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 14. DERMOCOSMETICS MARKET SIZE, FOR ONLINE, BY REGION, 2021-2030 ($MILLION)
  • TABLE 15. DERMOCOSMETICS MARKET FOR ONLINE BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 16. GLOBAL DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 17. DERMOCOSMETICS MARKET SIZE, FOR CLINICS, MEDICAL SPAS, AND SALONS, BY REGION, 2021-2030 ($MILLION)
  • TABLE 18. DERMOCOSMETICS MARKET FOR CLINICS, MEDICAL SPAS, AND SALONS BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 19. DERMOCOSMETICS MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2030 ($MILLION)
  • TABLE 20. DERMOCOSMETICS MARKET FOR HOSPITALS BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 21. DERMOCOSMETICS MARKET SIZE, FOR AT-HOME, BY REGION, 2021-2030 ($MILLION)
  • TABLE 22. DERMOCOSMETICS MARKET FOR AT-HOME BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 23. DERMOCOSMETICS MARKET, BY REGION, 2021-2030 ($MILLION)
  • TABLE 24. NORTH AMERICA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 25. NORTH AMERICA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 26. NORTH AMERICA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 27. NORTH AMERICA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 28. NORTH AMERICA DERMOCOSMETICS MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 29. U.S. DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 30. U.S. DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 31. U.S. DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 32. U.S. DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 33. CANADA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 34. CANADA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 35. CANADA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 36. CANADA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 37. MEXICO DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 38. MEXICO DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 39. MEXICO DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 40. MEXICO DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 41. EUROPE DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 42. EUROPE DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 43. EUROPE DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 44. EUROPE DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 45. EUROPE DERMOCOSMETICS MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 46. GERMANY DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 47. GERMANY DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 48. GERMANY DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 49. GERMANY DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 50. FRANCE DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 51. FRANCE DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 52. FRANCE DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 53. FRANCE DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 54. ITALY DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 55. ITALY DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 56. ITALY DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 57. ITALY DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 58. SPAIN DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 59. SPAIN DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 60. SPAIN DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 61. SPAIN DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 62. UNITED KINGDOM DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 63. UNITED KINGDOM DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 64. UNITED KINGDOM DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 65. UNITED KINGDOM DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 66. REST OF EUROPE DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 67. REST OF EUROPE DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 68. REST OF EUROPE DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 69. REST OF EUROPE DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 70. ASIA-PACIFIC DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 71. ASIA-PACIFIC DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 72. ASIA-PACIFIC DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 73. ASIA-PACIFIC DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 74. ASIA-PACIFIC DERMOCOSMETICS MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 75. CHINA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 76. CHINA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 77. CHINA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 78. CHINA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 79. JAPAN DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 80. JAPAN DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 81. JAPAN DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 82. JAPAN DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 83. INDIA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 84. INDIA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 85. INDIA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 86. INDIA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 87. SOUTH KOREA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 88. SOUTH KOREA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 89. SOUTH KOREA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 90. SOUTH KOREA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 91. AUSTRALIA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 92. AUSTRALIA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 93. AUSTRALIA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 94. AUSTRALIA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 95. REST OF ASIA-PACIFIC DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 96. REST OF ASIA-PACIFIC DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 97. REST OF ASIA-PACIFIC DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 98. REST OF ASIA-PACIFIC DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 99. LAMEA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 100. LAMEA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 101. LAMEA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 102. LAMEA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 103. LAMEA DERMOCOSMETICS MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 104. BRAZIL DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 105. BRAZIL DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 106. BRAZIL DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 107. BRAZIL DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 108. SAUDI ARABIA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 109. SAUDI ARABIA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 110. SAUDI ARABIA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 111. SAUDI ARABIA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 112. UNITED ARAB EMIRATES DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 113. UNITED ARAB EMIRATES DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 114. UNITED ARAB EMIRATES DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 115. UNITED ARAB EMIRATES DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 116. SOUTH AFRICA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 117. SOUTH AFRICA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 118. SOUTH AFRICA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 119. SOUTH AFRICA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 120. REST OF LATIN AMERICA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 121. REST OF LATIN AMERICA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 122. REST OF LATIN AMERICA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 123. REST OF LATIN AMERICA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 124.JOHNSON & JOHNSON, INC.: COMPANY SNAPSHOT
  • TABLE 125.JOHNSON & JOHNSON, INC.: OPERATING SEGMENTS
  • TABLE 126.JOHNSON & JOHNSON, INC.: PRODUCT PORTFOLIO
  • TABLE 127.JOHNSON & JOHNSON, INC.: NET SALES,
  • TABLE 128.JOHNSON & JOHNSON, INC.: KEY STRATERGIES
  • TABLE 129.BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT
  • TABLE 130.BAUSCH HEALTH COMPANIES INC.: OPERATING SEGMENTS
  • TABLE 131.BAUSCH HEALTH COMPANIES INC.: PRODUCT PORTFOLIO
  • TABLE 132.BAUSCH HEALTH COMPANIES INC.: NET SALES,
  • TABLE 133.BAUSCH HEALTH COMPANIES INC.: KEY STRATERGIES
  • TABLE 134.GALDERMA: COMPANY SNAPSHOT
  • TABLE 135.GALDERMA: OPERATING SEGMENTS
  • TABLE 136.GALDERMA: PRODUCT PORTFOLIO
  • TABLE 137.GALDERMA: NET SALES,
  • TABLE 138.GALDERMA: KEY STRATERGIES
  • TABLE 139.PROCTER & GAMBLE: COMPANY SNAPSHOT
  • TABLE 140.PROCTER & GAMBLE: OPERATING SEGMENTS
  • TABLE 141.PROCTER & GAMBLE: PRODUCT PORTFOLIO
  • TABLE 142.PROCTER & GAMBLE: NET SALES,
  • TABLE 143.PROCTER & GAMBLE: KEY STRATERGIES
  • TABLE 144.ALLERGAN PLC: COMPANY SNAPSHOT
  • TABLE 145.ALLERGAN PLC: OPERATING SEGMENTS
  • TABLE 146.ALLERGAN PLC: PRODUCT PORTFOLIO
  • TABLE 147.ALLERGAN PLC: NET SALES,
  • TABLE 148.ALLERGAN PLC: KEY STRATERGIES
  • TABLE 149.L'OREAL S.A: COMPANY SNAPSHOT
  • TABLE 150.L'OREAL S.A: OPERATING SEGMENTS
  • TABLE 151.L'OREAL S.A: PRODUCT PORTFOLIO
  • TABLE 152.L'OREAL S.A: NET SALES,
  • TABLE 153.L'OREAL S.A: KEY STRATERGIES
  • TABLE 154.BEIERSDORF: COMPANY SNAPSHOT
  • TABLE 155.BEIERSDORF: OPERATING SEGMENTS
  • TABLE 156.BEIERSDORF: PRODUCT PORTFOLIO
  • TABLE 157.BEIERSDORF: NET SALES,
  • TABLE 158.BEIERSDORF: KEY STRATERGIES
  • TABLE 159.KANEBO COSMETICS INC.: COMPANY SNAPSHOT
  • TABLE 160.KANEBO COSMETICS INC.: OPERATING SEGMENTS
  • TABLE 161.KANEBO COSMETICS INC.: PRODUCT PORTFOLIO
  • TABLE 162.KANEBO COSMETICS INC.: NET SALES,
  • TABLE 163.KANEBO COSMETICS INC.: KEY STRATERGIES
  • TABLE 164.ESTEE LAUDER COMPANIES INC.: COMPANY SNAPSHOT
  • TABLE 165.ESTEE LAUDER COMPANIES INC.: OPERATING SEGMENTS
  • TABLE 166.ESTEE LAUDER COMPANIES INC.: PRODUCT PORTFOLIO
  • TABLE 167.ESTEE LAUDER COMPANIES INC.: NET SALES,
  • TABLE 168.ESTEE LAUDER COMPANIES INC.: KEY STRATERGIES
  • TABLE 169.SHISEIDO COMPANY: COMPANY SNAPSHOT
  • TABLE 170.SHISEIDO COMPANY: OPERATING SEGMENTS
  • TABLE 171.SHISEIDO COMPANY: PRODUCT PORTFOLIO
  • TABLE 172.SHISEIDO COMPANY: NET SALES,
  • TABLE 173.SHISEIDO COMPANY: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.DERMOCOSMETICS MARKET SEGMENTATION
  • FIGURE 2.DERMOCOSMETICS MARKET,2021-2030
  • FIGURE 3.DERMOCOSMETICS MARKET,2021-2030
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.DERMOCOSMETICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.VALUE CHAIN ANALYSIS
  • FIGURE 13.MARKET SHARE ANALYSIS
  • FIGURE 14.REGULATORY GUIDELINES
  • FIGURE 15.KEY REGULATION ANALYSIS
  • FIGURE 16.PATENT ANALYSIS BY COMPANY
  • FIGURE 17.PATENT ANALYSIS BY COUNTRY
  • FIGURE 18.DERMOCOSMETICS MARKET,BY PRODUCT,2021(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF SKIN CARE DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HAIR CARE DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 21.DERMOCOSMETICS MARKET,BY TREATMENT,2021(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SKIN DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HAIR DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 24.DERMOCOSMETICS MARKET,BY DISTRIBUTION CHANNEL,2021(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF PHARMACY AND RETAIL STORES DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF ONLINE DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 27.DERMOCOSMETICS MARKET,BY END-USER,2021(%)
  • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF CLINICS, MEDICAL SPAS, AND SALONS DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 29.COMPARATIVE SHARE ANALYSIS OF HOSPITALS DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 30.COMPARATIVE SHARE ANALYSIS OF AT-HOME DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 31.DERMOCOSMETICS MARKET BY REGION,2021
  • FIGURE 32.U.S. DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 33.CANADA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 34.MEXICO DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 35.GERMANY DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 36.FRANCE DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 37.ITALY DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 38.SPAIN DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 39.UNITED KINGDOM DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 40.REST OF EUROPE DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 41.CHINA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 42.JAPAN DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 43.INDIA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 44.SOUTH KOREA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 45.AUSTRALIA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 46.REST OF ASIA-PACIFIC DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 47.BRAZIL DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 48.SAUDI ARABIA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 49.UNITED ARAB EMIRATES DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 50.SOUTH AFRICA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 51.REST OF LATIN AMERICA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 52. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 53. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 54. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 55.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 56.COMPETITIVE DASHBOARD
  • FIGURE 57.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 58.JOHNSON & JOHNSON, INC..: NET SALES ,($MILLION)
  • FIGURE 59.BAUSCH HEALTH COMPANIES INC..: NET SALES ,($MILLION)
  • FIGURE 60.GALDERMA.: NET SALES ,($MILLION)
  • FIGURE 61.PROCTER & GAMBLE.: NET SALES ,($MILLION)
  • FIGURE 62.ALLERGAN PLC.: NET SALES ,($MILLION)
  • FIGURE 63.L'OREAL S.A.: NET SALES ,($MILLION)
  • FIGURE 64.BEIERSDORF.: NET SALES ,($MILLION)
  • FIGURE 65.KANEBO COSMETICS INC..: NET SALES ,($MILLION)
  • FIGURE 66.ESTEE LAUDER COMPANIES INC..: NET SALES ,($MILLION)
  • FIGURE 67.SHISEIDO COMPANY.: NET SALES ,($MILLION)